|Denaro||120,94 x 900|
|Lettera||120,94 x 3200|
|Min-Max giorno||120,18 - 121,78|
|Intervallo di 52 settimane||98,67 - 128,54|
|Beta (5 anni mensile)||0,68|
|Rapporto PE (ttm)||34,06|
|Prossima data utili||19 ott 2021 - 25 ott 2021|
|Rendimento e dividendo (forward)||1,80 (1,49%)|
|Data ex dividendo||14 lug 2021|
|Stima target 1A||125,95|
The Illinois-based medical devices and health care company Abbott Laboratories’ shares slumped about 8% on Tuesday after the company slashed its full-year 2021 profit outlook due to significantly lower recent and projected COVID-19 diagnostic testing demand.
For decades, income-minded investors have searched for the best dividend stocks out there.
Illinois-based medical devices and health care company Abbott Laboratories’ shares fell over 3% on Tuesday after the company missed earnings and revenue estimates for the first quarter.